reldesemtiv

As Cytokinetics’s ALS drug fails Phase III, focus turns to cardiomyopathy candidate
Clinical Trials Arena
Mon, 04/24/23 - 11:23 am
Cytokinetics
clinical trials
ALS
reldesemtiv
cardiomyopathy
aficamten
Cytokinetics’ pipeline tumble continues after ALS med flops in phase 3 interim look
Fierce Biotech
Sun, 04/2/23 - 04:00 pm
Cytokinetics
ALS
clinical trials
reldesemtiv
Cytokinetics' comeback attempt with second-gen drug is slammed by a PhII failure in ALS
Endpoints
Sun, 05/5/19 - 06:59 pm
Cytokinetics
clinical trials
reldesemtiv
ALS
After a crushing PhIII failure, Cytokinetics says its next-gen muscle drug is lining up well in PhII — but big challenges loom
Endpoints
Mon, 06/18/18 - 10:00 am
Cytokinetics
clinical trials
reldesemtiv
Tirasemtiv
spinal muscular atrophy
Astellas